Peptide purity, identity, content and sterility
A high purity percentage answers only one analytical question. Identity, measured amount, sterility, endotoxin and batch traceability are separate questions that need separate evidence.
By Manchester Peptides ·
Why one percentage is not the whole story
A laboratory result should be interpreted according to the test that produced it. A chromatographic purity value may describe the relative proportion of detected material assigned to a main peak under stated conditions. It does not automatically prove that the peak is the intended peptide, that the vial contains the labelled amount, or that the sample is sterile.
The most useful reports clearly identify the submitted sample, methods, units, measured results and limitations. A certificate should also be traceable to a task number, batch or sample description and an independent verification route where the laboratory provides one.
Identity: is the material what the label says?
Identity testing asks whether the sample is consistent with the stated molecule. Mass spectrometry can compare an observed mass with an expected molecular mass, while other techniques may add sequence or structural information. A purity chromatogram without suitable identity evidence can show that one component dominates the sample without proving what that component is.
Purity: what proportion belongs to the main detected component?
Purity is method-dependent. HPLC and related separation techniques can estimate the proportion of detected peaks under the method conditions. The result depends on sample preparation, detection wavelength, integration rules, reference standards and whether particular impurities are detectable by that method.
A value such as 99% should therefore be read with the method and chromatogram. It is not a universal percentage covering water, salts, residual solvents, metals, microbes or endotoxin.
Content or quantity: how much was measured?
Content testing asks how much of the stated analyte is present. It may be reported in milligrams, international units or another defined unit. A vial can show high chromatographic purity but contain less or more material than its label states. Conversely, a measured total near the label claim does not by itself prove identity or sterility.
For complexes or blends, the report should make clear whether each component was measured separately. GHK-Cu, for example, may be described using peptide content, copper content and combined total; those numbers should not be treated as interchangeable.
Sterility and endotoxin: different contamination questions
Sterility testing investigates viable microorganisms under defined conditions. Endotoxin testing addresses bacterial endotoxins, which can remain even when viable bacteria are not detected. Neither result is established by HPLC purity or mass spectrometry.
A report that does not list sterility or endotoxin testing should be read as not reporting those characteristics. Silence on a certificate is not a passing result.
Batch traceability: does the report match the item?
A genuine report can still be irrelevant to the material in front of a reader. Match the laboratory, task number, sample description, batch identifier, testing date and labelled strength. If the website cannot establish that a report belongs to the exact catalogue batch, it should be described as a reference report rather than batch-specific proof.
A practical five-question check
- What exact sample and batch were submitted?
- Which analytical methods were used?
- Does the report separately address identity, purity and amount?
- Are sterility or endotoxin results actually listed?
- Can the task number or verification key be checked with the named laboratory?
What a COA cannot establish by itself
A COA does not automatically establish clinical safety, effectiveness, regulatory approval, manufacturing consistency across batches, stability after transport, or suitability for a particular use. Those questions require different evidence and controls.